市場調查報告書
商品編碼
997489

缺鐵性貧血治療的全球市場

Iron Deficiency Anemia Therapy

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

全球缺鐵性貧血治療的市場規模,預計在分析期間(2020年∼2027年)將以6%的年複合成長率增長,從2020年的26億美元,到2027年達到40億美元。

本報告所分析的市場區隔之一的口服鐵劑療法部門,在分析期間中預計將以5.8%的年複合成長率增長,達到19億美元。

本報告提供全球缺鐵性貧血治療市場的相關調查,提供市場佔有率,Covid-19的影響,趨勢和成長要素,各地區的市場分析,競爭情形,主要企業的簡介等資訊。

調查對象企業範例

  • Allergan PLC
  • AMAG Pharmaceuticals, Inc.
  • Johnson & Johnson
  • Keryx Biopharmaceuticals, Inc.
  • Luitpold Pharmaceuticals, Inc.
  • Pharmacosmos A/S
  • Pieris Pharmaceuticals, Inc.

目錄

I. 調查手法

II. 摘要整理

  • 市場概要
    • 影響者市場洞察
    • 全球市場的軌跡
    • Covid-19的影響與即將到來的全球景氣衰退
  • 主要企業
  • 趨勢與推動要素
  • 全球市場預測

III. 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 南美
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他南美國家
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東
  • 非洲

IV. 競爭

  • 企業簡介:38公司
目錄
Product Code: MCP12863

Abstract:

Global Iron Deficiency Anemia Therapy Market to Reach $4 Billion by 2027

Amid the COVID-19 crisis, the global market for Iron Deficiency Anemia Therapy estimated at US$2.6 Billion in the year 2020, is projected to reach a revised size of US$4 Billion by 2027, growing at a CAGR of 6% over the analysis period 2020-2027. Oral Iron Therapy, one of the segments analyzed in the report, is projected to record a 5.8% CAGR and reach US$1.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Parenteral Iron Therapy segment is readjusted to a revised 6.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $715.2 Million, While China is Forecast to Grow at 9.1% CAGR

The Iron Deficiency Anemia Therapy market in the U.S. is estimated at US$715.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$840.2 Million by the year 2027 trailing a CAGR of 9.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.3% and 5.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Red Blood Cell Transfusion Segment to Record 6.9% CAGR

In the global Red Blood Cell Transfusion segment, USA, Canada, Japan, China and Europe will drive the 6.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$239.2 Million in the year 2020 will reach a projected size of US$367 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$535.8 Million by the year 2027, while Latin America will expand at a 8.2% CAGR through the analysis period.

Select Competitors (Total 38 Featured) -

  • Allergan PLC
  • AMAG Pharmaceuticals, Inc.
  • Johnson & Johnson
  • Keryx Biopharmaceuticals, Inc.
  • Luitpold Pharmaceuticals, Inc.
  • Pharmacosmos A/S
  • Pieris Pharmaceuticals, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Iron Deficiency Anemia Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Iron Deficiency Anemia Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Iron Deficiency Anemia Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Oral Iron Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Oral Iron Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Oral Iron Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Parenteral Iron Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Parenteral Iron Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Parenteral Iron Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Red Blood Cell Transfusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Red Blood Cell Transfusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Red Blood Cell Transfusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Other therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Other therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Other therapies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 16: USA Current & Future Analysis for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 17: USA Historic Review for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 18: USA 15-Year Perspective for Iron Deficiency Anemia Therapy by Type of Therapy - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 19: Canada Current & Future Analysis for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 20: Canada Historic Review for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 21: Canada 15-Year Perspective for Iron Deficiency Anemia Therapy by Type of Therapy - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 22: Japan Current & Future Analysis for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 23: Japan Historic Review for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 24: Japan 15-Year Perspective for Iron Deficiency Anemia Therapy by Type of Therapy - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 25: China Current & Future Analysis for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 26: China Historic Review for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 27: China 15-Year Perspective for Iron Deficiency Anemia Therapy by Type of Therapy - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 28: Europe Current & Future Analysis for Iron Deficiency Anemia Therapy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 29: Europe Historic Review for Iron Deficiency Anemia Therapy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 30: Europe 15-Year Perspective for Iron Deficiency Anemia Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 31: Europe Current & Future Analysis for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 32: Europe Historic Review for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 33: Europe 15-Year Perspective for Iron Deficiency Anemia Therapy by Type of Therapy - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 34: France Current & Future Analysis for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 35: France Historic Review for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 36: France 15-Year Perspective for Iron Deficiency Anemia Therapy by Type of Therapy - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 37: Germany Current & Future Analysis for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Germany Historic Review for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 39: Germany 15-Year Perspective for Iron Deficiency Anemia Therapy by Type of Therapy - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 40: Italy Current & Future Analysis for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 41: Italy Historic Review for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 42: Italy 15-Year Perspective for Iron Deficiency Anemia Therapy by Type of Therapy - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 43: UK Current & Future Analysis for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 44: UK Historic Review for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 45: UK 15-Year Perspective for Iron Deficiency Anemia Therapy by Type of Therapy - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies for the Years 2012, 2020 & 2027
  • SPAIN
    • TABLE 46: Spain Current & Future Analysis for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 47: Spain Historic Review for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 48: Spain 15-Year Perspective for Iron Deficiency Anemia Therapy by Type of Therapy - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies for the Years 2012, 2020 & 2027
  • RUSSIA
    • TABLE 49: Russia Current & Future Analysis for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Russia Historic Review for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 51: Russia 15-Year Perspective for Iron Deficiency Anemia Therapy by Type of Therapy - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 52: Rest of Europe Current & Future Analysis for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Rest of Europe Historic Review for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 54: Rest of Europe 15-Year Perspective for Iron Deficiency Anemia Therapy by Type of Therapy - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 55: Asia-Pacific Current & Future Analysis for Iron Deficiency Anemia Therapy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 56: Asia-Pacific Historic Review for Iron Deficiency Anemia Therapy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 57: Asia-Pacific 15-Year Perspective for Iron Deficiency Anemia Therapy by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
    • TABLE 58: Asia-Pacific Current & Future Analysis for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 59: Asia-Pacific Historic Review for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 60: Asia-Pacific 15-Year Perspective for Iron Deficiency Anemia Therapy by Type of Therapy - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies for the Years 2012, 2020 & 2027
  • AUSTRALIA
    • TABLE 61: Australia Current & Future Analysis for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 62: Australia Historic Review for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 63: Australia 15-Year Perspective for Iron Deficiency Anemia Therapy by Type of Therapy - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies for the Years 2012, 2020 & 2027
  • INDIA
    • TABLE 64: India Current & Future Analysis for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 65: India Historic Review for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 66: India 15-Year Perspective for Iron Deficiency Anemia Therapy by Type of Therapy - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies for the Years 2012, 2020 & 2027
  • SOUTH KOREA
    • TABLE 67: South Korea Current & Future Analysis for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 68: South Korea Historic Review for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 69: South Korea 15-Year Perspective for Iron Deficiency Anemia Therapy by Type of Therapy - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies for the Years 2012, 2020 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 70: Rest of Asia-Pacific Current & Future Analysis for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Rest of Asia-Pacific Historic Review for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 72: Rest of Asia-Pacific 15-Year Perspective for Iron Deficiency Anemia Therapy by Type of Therapy - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies for the Years 2012, 2020 & 2027
  • LATIN AMERICA
    • TABLE 73: Latin America Current & Future Analysis for Iron Deficiency Anemia Therapy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 74: Latin America Historic Review for Iron Deficiency Anemia Therapy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 75: Latin America 15-Year Perspective for Iron Deficiency Anemia Therapy by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
    • TABLE 76: Latin America Current & Future Analysis for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 77: Latin America Historic Review for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 78: Latin America 15-Year Perspective for Iron Deficiency Anemia Therapy by Type of Therapy - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies for the Years 2012, 2020 & 2027
  • ARGENTINA
    • TABLE 79: Argentina Current & Future Analysis for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 80: Argentina Historic Review for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 81: Argentina 15-Year Perspective for Iron Deficiency Anemia Therapy by Type of Therapy - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies for the Years 2012, 2020 & 2027
  • BRAZIL
    • TABLE 82: Brazil Current & Future Analysis for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 83: Brazil Historic Review for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 84: Brazil 15-Year Perspective for Iron Deficiency Anemia Therapy by Type of Therapy - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies for the Years 2012, 2020 & 2027
  • MEXICO
    • TABLE 85: Mexico Current & Future Analysis for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Mexico Historic Review for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 87: Mexico 15-Year Perspective for Iron Deficiency Anemia Therapy by Type of Therapy - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies for the Years 2012, 2020 & 2027
  • REST OF LATIN AMERICA
    • TABLE 88: Rest of Latin America Current & Future Analysis for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Rest of Latin America Historic Review for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 90: Rest of Latin America 15-Year Perspective for Iron Deficiency Anemia Therapy by Type of Therapy - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies for the Years 2012, 2020 & 2027
  • MIDDLE EAST
    • TABLE 91: Middle East Current & Future Analysis for Iron Deficiency Anemia Therapy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 92: Middle East Historic Review for Iron Deficiency Anemia Therapy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 93: Middle East 15-Year Perspective for Iron Deficiency Anemia Therapy by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
    • TABLE 94: Middle East Current & Future Analysis for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Middle East Historic Review for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 96: Middle East 15-Year Perspective for Iron Deficiency Anemia Therapy by Type of Therapy - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies for the Years 2012, 2020 & 2027
  • IRAN
    • TABLE 97: Iran Current & Future Analysis for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Iran Historic Review for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 99: Iran 15-Year Perspective for Iron Deficiency Anemia Therapy by Type of Therapy - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies for the Years 2012, 2020 & 2027
  • ISRAEL
    • TABLE 100: Israel Current & Future Analysis for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 101: Israel Historic Review for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 102: Israel 15-Year Perspective for Iron Deficiency Anemia Therapy by Type of Therapy - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies for the Years 2012, 2020 & 2027
  • SAUDI ARABIA
    • TABLE 103: Saudi Arabia Current & Future Analysis for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 104: Saudi Arabia Historic Review for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 105: Saudi Arabia 15-Year Perspective for Iron Deficiency Anemia Therapy by Type of Therapy - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies for the Years 2012, 2020 & 2027
  • UNITED ARAB EMIRATES
    • TABLE 106: UAE Current & Future Analysis for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 107: UAE Historic Review for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 108: UAE 15-Year Perspective for Iron Deficiency Anemia Therapy by Type of Therapy - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies for the Years 2012, 2020 & 2027
  • REST OF MIDDLE EAST
    • TABLE 109: Rest of Middle East Current & Future Analysis for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 110: Rest of Middle East Historic Review for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 111: Rest of Middle East 15-Year Perspective for Iron Deficiency Anemia Therapy by Type of Therapy - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies for the Years 2012, 2020 & 2027
  • AFRICA
    • TABLE 112: Africa Current & Future Analysis for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 113: Africa Historic Review for Iron Deficiency Anemia Therapy by Type of Therapy - Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 114: Africa 15-Year Perspective for Iron Deficiency Anemia Therapy by Type of Therapy - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion and Other therapies for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 38